Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy.

Journal of human genetics - 1 May 2013

Toyota Kentaro, Hashimoto Taeko, Ogino Daisuke, Matsunaga Akira, Ito Minoru, Masakane Ikuto, Degawa Noriyuki, Sato Hiroshi, Shirai Sayuri, Umetsu Kazuo, Tamiya Gen, Saito Takao, Hayasaka Kiyoshi

Abstract excerpt

Lipoprotein glomerulopathy (LPG) is a hereditary disease characterized by lipoprotein thrombi in the glomerulus, hyperlipoproteinemia, and a marked increase in serum apolipoprotein E (APOE). More than 12 APOE mutations have been identified as causes of LPG, and APOE-Sendai (Arg145Pro) mutation was frequently detected in patients from the eastern part of Japan including Yamagata prefecture. Recently, effective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins E
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Founder Effect

Share to Gene Order

Share to Haplotypes

Share to Kidney Diseases

Share to Renal Dialysis

Source

Identifiers

PMID: 23407349
DOI: 10.1038/jhg.2013.8

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy.PMID 23407349Read ↗

Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations.Semantic proximity Read ↗

Common apolipoprotein E gene mutations contribute to lipoprotein glomerulopathy in China.Semantic proximity Read ↗

Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient miceSemantic proximity Read ↗

A novel apolipoprotein E mutation, ApoE Ganzhou (Arg43Cys), in a Chinese son and his father with lipoprotein glomerulopathy: two case reports.Semantic proximity Read ↗

Lipoprotein glomerulopathy may provide a key to unlock the puzzles of renal lipidosis.Semantic proximity Read ↗

Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice.Semantic proximity Read ↗

Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation.Semantic proximity Read ↗

Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy.Semantic proximity Read ↗

<i>APOE</i>Kyoto Mutation in European Americans with Lipoprotein GlomerulopathySemantic proximity Read ↗

[Discovery of a Chinese Tibetan patient with lipoprotein glomerulopathy due to APOE Osaka/Kurashiki variant].Semantic proximity Read ↗

The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.Semantic proximity Read ↗

Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.